Bo Hui innovation and investment projects slow down production capacity severely tight

Great Wisdom aastocks News agency January 14, Bo Hui Innovation (300318.SZ) performance in the fourth quarter to achieve accelerated, is expected to increase the annual performance of 5%-15%, so that the market attention. However, the main reason for the growth was the increase in government subsidy and interest income. The Big Wisdom News agency noted that the innovation is expected to ease the current tight production capacity of the investment project progress is rather slow, and business expansion is also hampered. The investment project is progressing slowly, not up to expectations. In fact, the 2013-Year progress of the project has been very slow. The 2012 annual report revealed that the project was progressing at 51.61%, expected to be put into use by the end of 2013, and said it would relocate to an integrated research and development base by the end of 2013. The progress of the 2013.5 Annual report and the disclosure of the three quarterly reports were 55.95% and 57.69%, which were almost turtle speed. The company prospectus shows that the comprehensive research and development base construction project is expected to reach the expected December 31, 2013 use status. Built up to the postpartum, in the field of intestinal virus detection, will add products immunofluorescence Analyzer 500 units/year and immunofluorescence method rotavirus, intestinal adenovirus detection kit 5 million/year; At the same time, in the field of human trace elements, production capacity will increase to 800 units of human body trace elements detection equipment and preparation of 1760 Million human body trace elements detection reagents. In Tuesday, the company's securities department told the Big Intelligence news agency that the investment project was not currently in the expected state of use. Severely strained capacity, business development limited to the innovation of the current business focus on human trace element detection in the field of child detection market-oriented, while the human body trace elements detection instruments and testing reagents capacity ceiling is coming. The importance of the above-mentioned projects to the company is self-evident. In addition to the product structure will be further enriched, production capacity will also be greatly increased, the area of product coverage will be from the existing child detection market to expand market demand potential of the adult detection market. One industry Personage said, the investment project progress slowly puzzling, not only causes the capacity to continue severely tight, to the company in the new domain expansion also to bring certain constraints. From the Bo-hui innovative product structure, the human body trace elements detection instruments and testing reagents capacity of 6 million units, 12 million, the current capacity utilization ratio has been more than 100%. In fact, starting in 2011, the company's capacity has broken 100%. 2011, 2012 the output of the two products are 8.46 million units, 9.57 million units and 15.57 million, 16.99 million, and maintain more than 10% of the growth rate, the capacity of the ceiling is coming.